Literature DB >> 16012909

Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.

Teresa Wierzba-Bobrowicz1, Eliza Lewandowska, Waldemar Lechowicz, Tomasz Stepień, Elzbieta Pasennik.   

Abstract

Under pathological conditions, microglial cells undergo activation, which is manifested by the expression of histocompatibility locus antigens class II (HLA II) on their surface as well as by proliferation and varied morphological forms. In schizophrenia, characterised by an essential role played by immunological mechanisms, quantitative analysis of activated microglia -- with well-developed ramification (RM), degenerative traits and damaged processes (from their shortening to their complete lack) (DM) -- may contribute to better understanding of schizophrenia etiopathogenesis. Quantitative analysis was performed on slices derived from the frontal and temporal lobes of 9 brains of schizophrenics and 6 control brains. The nonparametric Mann-Whitney U test was used to assess quantitative differences in the distribution of microglia in these regions of the brain. Statistical analyses were performed with STATISTICA 6.5 Programme. In both structures of the brain, the number of activated microglial cells was higher in schizophrenic brains than in control brains. Except for the first layer of the cerebral cortex with the same amounts of RM and DM, the number of DM cells in the remaining regions was several-fold higher than that of RM cells. It is most likely that disturbances in calcium metabolism and energetic balance as well as antibodies produced in the course of schizophrenia are the agents able to trigger a cascade transforming RM into DM. Quantitative differences in RM and DM, observed between the studied structures and cortical regions, could depend not only on functioning of inter-neuronal and inter-structural links. Our study suggests a pivotal role of microglial cells in repair processes and/or etiopathogenesis of schizophrenia and indicates that they undergo substantial damage in the course of chronic schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 16012909

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  41 in total

Review 1.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 3.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

Review 4.  Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.

Authors:  David W Volk
Journal:  Neurobiol Dis       Date:  2016-12-19       Impact factor: 5.996

5.  The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress.

Authors:  Karina S MacDowell; Javier R Caso; David Martín-Hernández; Beatriz M Moreno; José L M Madrigal; Juan A Micó; Juan C Leza; Borja García-Bueno
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

6.  Molecular mechanisms and timing of cortical immune activation in schizophrenia.

Authors:  David W Volk; Anjani Chitrapu; Jessica R Edelson; Kaitlyn M Roman; Annie E Moroco; David A Lewis
Journal:  Am J Psychiatry       Date:  2015-07-02       Impact factor: 18.112

7.  Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.

Authors:  Miran Kenk; Thiviya Selvanathan; Naren Rao; Ivonne Suridjan; Pablo Rusjan; Gary Remington; Jeffrey H Meyer; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

8.  Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study.

Authors:  Konasale M Prasad; Catherine H Upton; Vishwajit L Nimgaonkar; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2014-10-22       Impact factor: 4.939

9.  Serum S100B: a potential biomarker for suicidality in adolescents?

Authors:  Tatiana Falcone; Vincent Fazio; Catherine Lee; Barry Simon; Kathleen Franco; Nicola Marchi; Damir Janigro
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.

Authors:  William C Kreisl; Kimberly J Jenko; Christina S Hines; Chul Hyoung Lyoo; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Thomas Hyde; Joel E Kleinman; Victor W Pike; Francis J McMahon; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.